☰

Study finds glioblastoma patients treated with bevacizumab experience reduced cognitive function and quality of life




Many glioblastoma patients treated with bevacizumab (Avastin®) have significant deterioration in neurocognitive function, symptoms and quality of life.

Fuente : http://www.eurekalert.org/pub_releases/2013-06/uot...

Sábado, 1 de Junio 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección